Revolution Medicines, Inc. (RVMDW)

NASDAQ: RVMDW · Real-Time Price · USD · Warrants
0.2750
+0.0150 (5.77%)
Jul 28, 2025, 4:00 PM - Market closed
5.77%
Market Cap6.94B
Revenue (ttm)n/a
Net Income (ttm)-697.51M
Shares Out 186.27M
EPS (ttm)-4.02
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,135
Open0.2750
Previous Close0.2600
Day's Range0.2550 - 0.2750
52-Week Range0.0305 - 0.8000
Beta1.10
Analystsn/a
Price Targetn/a
Earnings DateFeb 26, 2025

About RVMDW

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company’s research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236)... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 534
Stock Exchange NASDAQ
Ticker Symbol RVMDW
Full Company Profile

News

There is no news available yet.